FDA Inspection 1119400 — G&C Pharmaceuticals, Inc.
The FDA completed an inspection of G&C Pharmaceuticals, Inc. on February 24, 2020 in Moca, PR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Food/Cosmetics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 24, 2020
- Fiscal Year
- 2020
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Moca, PR (United States)